Direxion Daily Healthcare Bull 3x Shares (CURE)
| Assets | $191.78M |
| NAV | $100.94 |
| Expense Ratio | 1.01% |
| PE Ratio | 27.20 |
| Shares Out | 1.90M |
| Dividend (ttm) | $0.07 |
| Dividend Yield | 0.06% |
| Ex-Dividend Date | Jun 22, 2022 |
| 1-Year Return | +1.15% |
| Volume | 102,547 |
| Open | 103.06 |
| Previous Close | 100.91 |
| Day's Range | 101.01 - 105.89 |
| 52-Week Low | 81.60 |
| 52-Week High | 149.57 |
| Beta | 2.51 |
| Holdings | 70 |
| Inception Date | Jun 15, 2011 |
About CURE
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Top 10 Holdings
68.01% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Sachs FS Treasury Intms Instl | FTIXX | 22.18% |
| Dreyfus Government Secs Cash Mgmt Admin | DAPXX | 10.13% |
| Johnson & Johnson | JNJ | 6.61% |
| UnitedHealth Group | UNH | 6.57% |
| Goldman Sachs FS Government Instl | FGTXX | 5.27% |
| Pfizer | PFE | 3.94% |
| AbbVie | ABBV | 3.73% |
| Eli Lilly and Company | LLY | 3.46% |
| Merck & Co. | MRK | 3.22% |
| Thermo Fisher Scientific | TMO | 2.91% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2022 | $0.03536 | Mar 29, 2022 |
| Dec 21, 2021 | $0.033 | Dec 29, 2021 |
| Dec 22, 2020 | $0.00609 | Dec 30, 2020 |
| Sep 22, 2020 | $0.01009 | Sep 29, 2020 |
| Jun 23, 2020 | $0.01627 | Jun 30, 2020 |
| Mar 24, 2020 | $0.09983 | Mar 31, 2020 |
News
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple levera...
5 Leveraged ETFs That Gained Double-Digits in December
Although inflationary fears and the rapidly spreading Omicron variant of COVID-19 have kept investors jittery, strong consumer confidence and a holiday sales surge have driven the market higher.
Latest Bills on Capitol Hill Tee Up Trades in These Two ETFs
The House of Representatives approved the trillion-dollar infrastructure bill last Friday night, opening up opportunities for a pair of ETF trades from Direxion Investments. The obvious play is to get b...
Tailwinds Are Blowing Behind Healthcare and the “CURE” ETF
Innovation-driven by rising demands on the healthcare system can create a strong growth environment for traders using the Direxion Daily Healthcare Bull 3X ETF (CURE). The rising population and improved...
5 Leveraged/Inverse ETFs Sizzling This Summer
Amid bouts of volatility and uncertainty, the Wall Street is sizzling this summer buoyed by solid corporate earnings growth and recovering economy.
3 ETFs to Access a Changing Pharmaceutical Industry
A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past ye...
Extra Bullish on Healthcare? Consider Leverage, the CURE ETF
The healthcare sector has always been seen as a safe investment, but given the way the pandemic has affected the industry, there may remain dynamic trading opportunities with the Direxion Daily Healthca...
5 Top-Performing Leveraged/Inverse ETFs of July
While earnings optimism and a rebounding economy pushed the three major indices to new highs in July, concerns about the spread of the Delta variant of COVID-19 made investors jittery.
Biden's Infrastructure Can Put These 2 Leveraged Funds in Play
U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bull...
Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021
Coronavirus vaccines are being distributed, but case counts continue rising, a pair of scenarios ensuring the healthcare center will again be an epicenter of activity in 2021. What Happened Healthcare i...
Healthcare Sector Is Gonna Get Exciting, Capture That With CURE
The healthcare sector is shaking off rust accrued earlier this year and with the 2020 election season mostly behind the group – pending next month's Georgia Senate runoff elections – market observers ar...
A Vaccine Is Coming. So What?
For the better part of 2020, the market has been ruled less by hard numbers and more by speculation about what the hard numbers may look like once the pandemic is “over” and things get back to “normal.”...
7 Top Leveraged ETFs of Last Week
Last week was moderately upbeat for Wall Street with vaccine hopes boosting the risk-on sentiments.
A CURE For The Common Earnings Play
It has the potential to be lost in this week's earnings hubbub, which is dominated by growth-ier communication services and technology stocks, but don't sleep on reports from blue-chip healthcare stocks.
Healthcare ETFs Are Hot Right Now, but Not All Are Created Equal
The coronavirus pandemic put healthcare exchange-traded funds (ETFs) in the forefront as medical providers are an essential component in the global market landscape. However, investors shouldn’t suck up...
Top Leveraged ETFs of Last Week
These leveraged ETFs won last week despite a broader market bloodbath.
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.
Best & Worst Leveraged ETFs of Last Week
Inside the top-and-worst-performing leveraged ETFs of last week.
5 Top-Performing Leveraged ETFs of November
Inside the best five best leveraged ETFs of November.